HLS Therapeutics Inc. (TSX:HLS)
Canada flag Canada · Delayed Price · Currency is CAD
4.590
-0.050 (-1.08%)
May 21, 2026, 4:00 PM EST

HLS Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
12.3311.7217.4621.9520.7221.18
Cash & Short-Term Investments
12.3311.7217.4621.9520.7221.18
Cash Growth
-30.50%-32.84%-20.48%5.93%-2.15%2.75%
Accounts Receivable
8.137.867.4510.611111.51
Inventory
7.368.149.069.538.98.93
Other Current Assets
1.131.371.4323.752.14
Total Current Assets
28.9529.0935.444.144.3743.75
Net Property, Plant & Equipment
1.171.3410.971.131.57
Other Intangible Assets
99.63105.63122.12162.34195.02229.18
Other Long-Term Assets
1.331.471.391.661.131.4
Total Assets
131.09137.53159.9209.06241.65275.91
Accounts Payable
9.9310.448.7114.1112.7910.6
Short-Term Debt
4.724.825.326.8815.4713.51
Other Current Liabilities
14.1810.878.525.712.933.57
Total Current Liabilities
28.8226.1222.5526.6931.1927.67
Long-Term Debt
40.8446.6861.9484.2384.5886.84
Other Long-Term Liabilities
2.863.064.070.440.570.65
Total Long-Term Liabilities
43.749.7466.0284.6885.1487.5
Total Liabilities
72.5275.8688.56111.36116.33115.17
Common Stock
256.34256.34260.6262.13265.21265.92
Additional Paid-in Capital
16.3916.1615.1413.8713.8211.72
Accumulated Other Comprehensive Income
-7.71-6.68-10.21-2.84-5.262.96
Retained Earnings
-206.45-204.15-194.18-175.46-148.45-119.86
Shareholders' Equity
58.5761.6771.3497.7125.32160.74
Total Liabilities & Equity
131.09137.53159.9209.06241.65275.91
Total Debt
45.5551.567.2691.11100.05100.35
Net Cash (Debt)
-33.23-39.77-49.81-69.16-79.33-79.17
Net Cash Per Share
-1.06-1.26-1.56-2.14-2.45-2.46
Book Value
58.5761.6771.3497.7125.32160.74
Book Value Per Share
1.871.962.243.033.864.99
Tangible Book Value
-41.06-43.96-50.78-64.65-69.7-68.45
Tangible Book Value Per Share
-1.31-1.39-1.59-2.00-2.15-2.13
Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.